19029533 12132992 23227426 29240814 14736753 21062121 15655339 12574948 15830059 15324723 14663391 20602579 15934446 30223711 11104196 21212679 17003722 - Search Results

Year	Number of Results
2000	1
2002	1
2003	2
2004	2
2005	3
2006	1
2008	1
2009	1
2010	2
2011	2
2012	1
2017	1
2018	1
2023	0

1

A noninvasive imaging approach to understanding speech changes following deep brain stimulation in Parkinson's disease.

Narayana S, Jacks A, Robin DA, Poizner H, Zhang W, Franklin C, Liotti M, Vogel D, Fox PT. Narayana S, et al. Am J Speech Lang Pathol. 2009 May;18(2):146-61. doi: 10.1044/1058-0360(2008/08-0004). Epub 2008 Nov 24. Am J Speech Lang Pathol. 2009. PMID: 19029533 Free PMC article. Review.

2

The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature.

Schulz GM. Schulz GM. Curr Med Chem. 2002 Jul;9(14):1359-66. doi: 10.2174/0929867023369808. Curr Med Chem. 2002. PMID: 12132992 Review.

3

Effect of deep brain stimulation on speech performance in Parkinson's disease.

Skodda S. Skodda S. Parkinsons Dis. 2012;2012:850596. doi: 10.1155/2012/850596. Epub 2012 Nov 21. Parkinsons Dis. 2012. PMID: 23227426 Free PMC article.

4

Towards the identification of Idiopathic Parkinson's Disease from the speech. New articulatory kinetic biomarkers.

Godino-Llorente JI, Shattuck-Hufnagel S, Choi JY, Moro-Velázquez L, Gómez-García JA. Godino-Llorente JI, et al. PLoS One. 2017 Dec 14;12(12):e0189583. doi: 10.1371/journal.pone.0189583. eCollection 2017. PLoS One. 2017. PMID: 29240814 Free PMC article.

5

Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.

Pinto S, Thobois S, Costes N, Le Bars D, Benabid AL, Broussolle E, Pollak P, Gentil M. Pinto S, et al. Brain. 2004 Mar;127(Pt 3):602-15. doi: 10.1093/brain/awh074. Epub 2004 Jan 21. Brain. 2004. PMID: 14736753

6

Spectral measures of the effects of Friedreich's ataxia on speech.

Rosen KM, Folker JE, Murdoch BE, Vogel AP, Cahill LM, Delatycki MB, Corben LA. Rosen KM, et al. Int J Speech Lang Pathol. 2011 Aug;13(4):329-34. doi: 10.3109/17549507.2011.529940. Epub 2010 Nov 9. Int J Speech Lang Pathol. 2011. PMID: 21062121

7

Task-based profile of vocal intensity decline in Parkinson's disease.

Rosen KM, Kent RD, Duffy JR. Rosen KM, et al. Folia Phoniatr Logop. 2005 Jan-Feb;57(1):28-37. doi: 10.1159/000081959. Folia Phoniatr Logop. 2005. PMID: 15655339

8

Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.

Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P. Pinto S, et al. J Neurol. 2003 Feb;250(2):179-87. doi: 10.1007/s00415-003-0966-7. J Neurol. 2003. PMID: 12574948 Clinical Trial.

9

Acoustic voice assessment in Parkinson's disease patients submitted to posteroventral pallidotomy.

Mourão LF, Aguiar PM, Ferraz FA, Behlau MS, Ferraz HB. Mourão LF, et al. Arq Neuropsiquiatr. 2005 Mar;63(1):20-5. doi: 10.1590/s0004-282x2005000100004. Epub 2005 Apr 13. Arq Neuropsiquiatr. 2005. PMID: 15830059 Free article.

10

Treatments for dysarthria in Parkinson's disease.

Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Pinto S, et al. Lancet Neurol. 2004 Sep;3(9):547-56. doi: 10.1016/S1474-4422(04)00854-3. Lancet Neurol. 2004. PMID: 15324723 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results